ARQT — ARCUTIS BIOTHERAPEUTICS INC

Ownership history in FISHMAN JAY A LTD/MI  ·  15 quarters on record

This page tracks every 13F SEC filing in which FISHMAN JAY A LTD/MI reported a position in ARCUTIS BIOTHERAPEUTICS INC (ARQT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.35% (2025 Q4)
Avg. % of fund
0.41%
First filed
2022 Q2
Last filed
2025 Q4
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 564,650 -1,000 -0.2% 1.35% $16.4M $29.04
2025 Q3 ADDED 565,650 +9,500 +1.7% 0.91% $10.7M $18.85
2025 Q2 ADDED 556,150 +23,000 +4.3% 0.75% $7.8M $14.02
2025 Q1 REDUCED 533,150 -3,250 -0.6% 0.91% $8.3M $15.64
11 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ARQT price (monthly, adj. close)

Other funds also holding ARQT

As of 2025 Q4 — sorted by position size

Pivotal bioVenture Partners Investment Advisor LLC 3Y 15.34% Frazier Life Sciences Management, L.P. 3Y 7.7% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 7.12% Rubric Capital Management LP 3Y 7Y 2.87% MPM BioImpact LLC 3Y 1.77% Privium Fund Management B.V. 3Y 1.64% MYDA Advisors LLC 3Y 7Y 1.47% GILDER GAGNON HOWE & CO LLC 3Y 7Y 1.37% Patient Square Capital LP 3Y 1.31% STEMPOINT CAPITAL LP 1.12%
← Back to FISHMAN JAY A LTD/MI Holdings